Using aspirin to prevent cognitive decline

BMJ

Volumn 337, Issue 7669, 2008, Pages 525-526

  Eikelboom, John W ^a   O'Donnell, Martin ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; NEUROPROTECTIVE AGENT;

ANXIETY; ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COGNITION; COGNITIVE DEFECT; DEATH; DEMENTIA; DEPRESSION; EDITORIAL; HEART INFARCTION; HUMAN; MEMORY; PRIORITY JOURNAL; STROKE; NOTE;

ASPIRIN; COGNITION DISORDERS; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 51649104711     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.a958     Document Type: Editorial

References (11)

1. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, et al. Mild cognitive impairment. Lancet 2006;367:1262-70.
2. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
3. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
4. O'Donnell MJ, Hankey GJ, Eikelboom JW. Antiplatelet therapy for secondary prevention of noncardioembolic ischemic stroke: a critical review. Stroke 2008;39:1638-46.
5. Nilsson SE, Johansson B, Takkinen S, Berg S, Zarit S, McClearn G, et al. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged > or =80 years. Eur J Clin Pharmacol 2003;59:313-9.
6. Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM, et al. No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 2008;70:2291-8.
7. Price JF, Stewart MC, Deary IJ, Murray GD, Sandercock P, Butcher I, et al. Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial. BMJ 2008;337:a1198.
8. Kang JH, Cook N, Manson J, Buring JE, Grodstein F. Low dose aspirin and cognitive function in the women's health study cognitive cohort. BMJ 2007;334:987.
9. Werring DJ, Frazer DW, Coward LJ, Losseff NA, Watt H, Cipolotti L, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004;127:2265-75.
10. Nelson M, Reid C, Beilin L, Donnan G, Johnston C, Krum H, et al. Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: aspirin in reducing events in the elderly (ASPREE). Drugs Aging 2003;20:897-903.
11. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure lowering with perindopril and Indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75.